Cellworks’ mission is to serve patients through advances in personalized medicine that significantly improve treatment success. We achieve better outcomes by predicting a successful match between patients and drug therapies – their Therapy Response Index (TRI). Our technology goes beyond the “one mutation, one drug” NGS paradigm, to consider multiple aberrations and to evaluate alternative therapy options, which provides actionable information and analysis.
In the clinical setting, our products provide physicians with a TRI report that informs therapy choices. We change the economics of drug development and targeting by assisting BioPharma in accomplishing higher clinical trial success rates and resurrecting failed drugs. We drive down costs across the healthcare system by cutting out the trial and error of therapy selection, and provide payors with transparency into the causative rationale of therapeutic recommendations. Critically, through early identification of the best therapy, we improve patient outcomes and save them from debilitating and costly rounds of unsuccessful treatment.
Cellworks’ personalized medicine products use AI-enhanced biosimulation to make phenotype predictions, which are then clinically validated. Our technology foundation is the Cellworks platform, which was conceived as a unified representation of biological knowledge collected from all known heterogeneous datasets. Our ground breaking and unconventional technology applies advanced modeling and quantitative prediction techniques that mirror the methodology used to design and validate semiconductor chips to simulate a patient’s response to FDA approved drugs, replacing trial and error in matching patients and therapies.
Founded in 2005 and backed by UnitedHealth Group, Sequoia Capital, Agilent and Artiman, Cellworks has built the world’s strongest trans-disciplinary team of molecular biologists, cellular pathway modelers and software technologists working towards a common goal of fighting disease to improve the lives of patients. Cellworks’ areas of therapeutic focus are oncology and immunology.
Our culture puts patients at the center of all our activities, driving innovation, motivating each of us to excel and deliver the most compelling therapies for the most confounding diseases.
We value science and innovation – we curate the world’s knowledge of biology and medicine, make it actionable and discover emergent characteristics.
We thrive on challenge and impact – provide us patients with complex medical problems that require precision medicine treatments. We will return with possible solutions.
We provide transparency and rationale – we provide patients with a transparently designed therapy accompanied by a full causative rationale. Each patient is always an n-of-one.
We instill teamwork and collaboration – Cellworks is about networks. As a cohesive team, Cellworks achieves more than as a collection of individuals.
We celebrate energy and passion – Cellworks is changing the world for patient outcomes. We always bring our best energy and our highest passion.